Joint Gi Society Message: Racism, Social Injustice and Our Pledge To Lead Change
Dear Colleagues:
The United States is experiencing the tragic consequences of racism.
As health care providers, we have...
Dear Colleagues:
The United States is experiencing the tragic consequences of racism.
As health care providers, we have...
Media Contact: Caroline Laurin
Phone: (703) 299-9766
Onsite phone: (415)-978-3601
Email: media@aasld.org
San Francisco –...
Media Contact: Caroline Laurin
Phone: (703) 299-9766
Email: media@aasld.org
Alexandria, VA – Data from a new study presented...
Media Contact: Caroline Laurin
Phone: (703) 299-9766
Onsite phone: (617)-954-2945
Email: media@aasld.org
Boston – Data from a...
Yunyang Deng, Junjie Huang, Martin C. S. Wong – 5 June 2022 – Diet is reported to be associated with hepatocellular carcinoma (HCC), but whether there is a causal relationship remains unclear. This study aimed to explore the potential causal associations between dietary habits and HCC risk using Mendelian randomization in an East Asian population.
Yong Qi, Wenping Gong – 5 June 2022
Nima Memaran, Hannes Wilke, Rizky I. Sugianto, Ulrich Baumann, Elena Bauer, Maxine Swallow, Esther Beuke, Norman Junge, Eva D. Pfister, Carl Grabitz, Nicolas Richter, Imeke Goldschmidt, Bernhard M. W. Schmidt, Anette Melk – 5 June 2022 – Leukocyte telomere length (LTL) is a marker for biological age. Pediatric liver transplant recipients show a high rate of subclinical atherosclerosis, indicated by elevated intima‐media thickness (IMT). We hypothesized that atherosclerosis is associated with biological age in these patients and investigated the course of LTL over time.
Jacqueline B. Henson, Kara Wegermann, Yuval A. Patel, Julius M. Wilder, Andrew J. Muir – 4 June 2022
Frank Tacke, Hartwig Klinker, Klaus H. W. Boeker, Uta Merle, Ralph Link, Peter Buggisch, Dietrich Hüppe, Markus Cornberg, Christoph Sarrazin, Heiner Wedemeyer, Thomas Berg, Stefan Mauss, DHC‐R – 4 June 2022 – While direct‐acting antivirals (DAAs) cure chronic hepatitis C virus (HCV) infection in almost all patients, some patients remain at risk of liver disease despite HCV cure.
Alexis Holman, Neehar Parikh, Dan J. Clauw, David A. Williams, Elliot B. Tapper – 4 June 2022 – Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding, renal injury, falls, and hepatic encephalopathy.